PharmaCyte Biotech Inc (PMCB): Investors should be concerned!! We we...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	42
Posts	4850
Boards Moderated	0
Alias Born	08/06/2012

frosr6

Re: None

Friday, 08/18/2017 12:49:56 AM

Friday, August 18, 2017 12:49:56 AM

Investors should be concerned!!

We were a party to the Bavarian Nordic/GSF License Agreement pursuant to which Bavarian Nordic/GSF are the licensors and Bio Blue Bird, our wholly owned subsidiary, is the licensee. The Bavarian Nordic/GSF License Agreement was signed in July 2005 and amended in December 2006 and October 2016. Pursuant to the Bavarian Nordic/GSF License, the licensee is granted an exclusive license to use Bavarian Nordic’s clinical data and know-how encapsulating genetically modified human cells to treat cancer and rights to Bio Blue Bird to the clinical data after expiration of the licensed patent rights. The licensors have rights to terminate the license if the annuity and upkeep fees are not paid to Bavarian Nordic, there is not proper reporting or there is not a clearly documented effort to commercialize this technology. The term of the Bavarian Nordic/GSF License Agreement expired on March 27, 2017, and the parties are currently negotiating an extension.

https://www.sec.gov/Archives/edgar/data/1157075/000168316817001881/pharmacyte_10k-043017.htm

Disclosure: I am involved in and support the SEC whistleblower program, I may be rewarded cash for information that leads to the successful enforcement by the SEC of a federal court or administrative action of 1m+.